
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 14.08 | 14.08 | 0.00 |
Shares | 85.92 | 85.92 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 10.81 | 19.61 |
Price to Book | 2.91 | 3.84 |
Price to Sales | 2.04 | 2.22 |
Price to Cash Flow | 8.54 | 14.84 |
Dividend Yield | 2.85 | 1.50 |
5 Years Earnings Growth | 7.23 | 10.20 |
Number of long holdings: 20
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Faes Farma | ES0134950F36 | 7.43 | 4.590 | +0.55% | |
Teva Pharmaceutical Industries Ltd ADR | - | 6.67 | - | - | |
Amgen Inc | - | 6.47 | - | - | |
Bristol-Myers Squibb Company | - | 5.47 | - | - | |
Eli Lilly and Co | - | 5.40 | - | - | |
Dr Reddy's Laboratories Ltd ADR | - | 5.32 | - | - | |
Novartis | CH0012005267 | 4.95 | 92.29 | -1.12% | |
Fresenius SE | DE0005785604 | 4.89 | 40.890 | -0.87% | |
Abbott Laboratories | - | 4.85 | - | - | |
Roche Holding Participation | CH0012032048 | 4.68 | 258.50 | +0.58% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
NB Global Flexible 0-50 FI | 30.04M | -1.81 | 3.28 | 0.79 | ||
JM Kapital Kairos | 27.27M | 3.12 | 8.61 | 0.95 | ||
NB Global Flexible 0-100 FI | 19.6M | -4.87 | 1.48 | 0.89 | ||
Fondibas FI | 21.67M | 3.91 | 8.47 | 1.68 | ||
GPM Abacus FI | 7.42M | 0.44 | 7.90 | 2.38 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review